...
首页> 外文期刊>Digestive Diseases and Sciences >Incidence and etiology of overt gastrointestinal bleeding in adult patients with aplastic anemia.
【24h】

Incidence and etiology of overt gastrointestinal bleeding in adult patients with aplastic anemia.

机译:成年再生障碍性贫血患者胃肠道出血的发生率和病因学。

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with thrombocytopenia caused by various neoplastic and primary bone marrow diseases are susceptible to major hemorrhage. There are few reports addressing the incidence and outcome of gastrointestinal (GI) bleeding in patients with aplastic anemia characterized by long-standing thrombocytopenia. We sought to retrospectively determine the incidence, etiology, clinical outcomes, and risk factors associated with overt GI bleeding in patients with aplastic anemia. We analyzed the medical records of 508 patients with aplastic anemia after excluding patients below 15 years of age or those who underwent stem cell transplantation between January 1, 2002, and December 31, 2007. A total of 32 patients developed overt GI bleeding during this period. We evaluated the site, etiology, outcomes, and major risk factors in these patients who developed GI bleeding episodes. The incidence of GI bleeding was 6.3% (32 of 508 patients) in adult patients with aplastic anemia. The incidence increased to 12.6% (28 of 222 patients) in patients with severe disease. One patient died from massive GI bleeding. Bleeding sites included the esophagus (two patients, 6.3%), stomach (five, 16.3%), duodenum (two, 6.3%), small intestine (five, 15.6%), large intestine (seven, 21.6%), and unknown site (11, 34.4%). Lower GI bleeds mainly caused by neutropenic enterocolitis (NEC) and solitary ulcer developed more frequently than upper GI bleeds. The major risk factors for GI bleeding included old age (P = 0.004, odds ratio (OR) = 1.039), severe aplastic anemia (P < 0.001, OR = 11.934), non-response to therapy (P = 0.001, OR = 5.652), and major bleeding history in another organ (P < 0.001, OR = 6.677). Overt GI bleeding in patients with aplastic anemia more frequently develops in the lower tract than in the upper tract. The risk of GI bleeding is higher in patients with the following risk factors: older age, severe disease, poor response to treatment, and major bleeding history in another organ.
机译:由各种肿瘤和原发性骨髓疾病引起的血小板减少症患者容易发生大出血。关于以再生障碍性血小板减少症为特征的再生障碍性贫血患者中胃肠道(GI)出血的发生率和结果的报道很少。我们试图回顾性确定再生障碍性贫血患者与明显胃肠道出血相关的发生率,病因,临床结局和危险因素。我们分析了508例再生障碍性贫血患者的病历,这些患者排除了15岁以下的患者或2002年1月1日至2007年12月31日期间进行干细胞移植的患者。在此期间,共有32例患者出现了明显的胃肠道出血。我们评估了这些发生胃肠道出血事件的患者的部位,病因,结局和主要危险因素。成年再生障碍性贫血患者的胃肠道出血发生率为6.3%(508例中的32例)。患有严重疾病的患者的发病率增至12.6%(222例患者中的28例)。一名患者死于大量胃肠道出血。出血部位包括食道(两名患者,占6.3%),胃(五个,占16.3%),十二指肠(两个,占6.3%),小肠(五个,占15.6%),大肠(七个,占21.6%)和未知部位(11,34.4%)。下消化道出血主要由中性粒细胞减少性小肠结肠炎(NEC)和孤立性溃疡引起,比上消化道出血更为频繁。胃肠道出血的主要危险因素包括老年(P = 0.004,优势比(OR)= 1.039),严重再生障碍性贫血(P <0.001,OR = 11.934),对治疗无反应(P = 0.001,OR = 5.652) ),以及其他器官的重大出血史(P <0.001,OR = 6.677)。再生障碍性贫血患者的明显胃肠道出血在上层比下层更常见。具有以下危险因素的患者中,胃肠道出血的风险较高:年龄较大,疾病严重,对治疗的反应较差以及其他器官的重大出血史。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号